Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.2825    0.0025 (0.89%)
Bid:
0.275
Ask:
0.29
Spread: 0.015 (5.455%)
Market Cap: £21.96m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Strong Commercial Progress

19 Jun 2018 07:00

RNS Number : 7811R
Haydale Graphene Industries PLC
19 June 2018
Β 

Β 

For immediate release

19 June 2018

Β 

Β 

Haydale Graphene Industries plc

Β 

('Haydale' or the 'Group')

Β 

Strong commercial progress in graphene-enhanced composites

Β 

Haydale, (AIM: HAYD), the global advanced materials group, is pleased to announce that strong commercial progress has been made with a global composite materials group (the "Customer") to enhance mechanical properties for selected productsΒ in their range of materials, through a commercially funded contract.

Β 

Over the last 12 months, Haydale has completed a series of pre-production trials for the Customer, who for commercial reasons cannot be named,Β to enhance these selected products' mechanical performance through the incorporation of graphene in a range of world-wide industrial applications. Haydale understands that the market sector for the Customers' products is significant within the global US$100bn composite market. To date, Haydale has been paid approximately US$150,000 by the Customer for these trials, which is included in the Group's current year revenue expectations.Β 

Β 

Trial quantity masterbatches were produced using Haydale's extensive knowledge of the most suitable commercially available graphene in consistent, repeatable quality. The graphene was sourced from an overseas supplier and, usingΒ Haydale's considerable in-house dispersion and mixing expertise, the required trial quantity masterbatch was produced. Crucially the trial quantities were specifically designed to be incorporated seamlessly into the Customer's production process.

Β 

Ray Gibbs, Chief Executive Officer of Haydale, commented: "This contract, fully funded by the Customer, is a perfect example of the work Haydale is doing across a range of composite product applications. We have experienced relatively long lead times with some of our past projects, but this one has been fast-tracked in response to the Customer's desire to launch as soon as possible."Β 

Β 

Keith Broadbent, Managing Director of Haydale's Resins, Polymers and Composites strategic business unit, said: "In a relatively short timeframe, Haydale has made excellent progress in delivering on the Customer's needs. It has been pleasing to see Haydale's composite engineers in Loughborough working well with the graphene functionalisation and dispersion team in Ammanford to combine their expertise and turn this major opportunity into a potentialΒ industrial product incorporating graphene."

Β 

- Ends -

Β 

For further information:

Haydale Graphene Industries plc

Ray Gibbs, Chief Executive Officer

Tel: +44 (0) 1269 842 946

Matt Wood, Finance Director

www.haydale.com

Gemma Smith Head of Marketing

Arden Partners plc (Nominated Adviser & Broker)

Ruari McGirr / Paul Shackleton / Ben Cryer

Tel: +44 (0) 20 7614 5900

Β 

Media enquiries:

Buchanan

Henry Harrison-Topham / Jamie Hooper /Gemma Mostyn-Owen

Tel: +44 (0) 20 7466 5000

haydale@buchanan.uk.com

www.buchanan.uk.com

Β 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

Β 

For more information please visit: www.haydale.comΒ 

Twitter: @haydalegraphene

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
NRAKMGMVRRKGRZM
Date   Source Headline
12th Jan 20227:00 amRNSFunding to Develop Anti-Counterfeiting Technology
11th Jan 20222:14 pmRNSResult of AGM
11th Jan 20227:00 amRNSGNPs Enhance Clothing for iCraft and Pro-Specs
10th Jan 20227:00 amRNSChange of Adviser
24th Dec 202112:41 pmRNSSecond Price Monitoring Extn
24th Dec 202112:35 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Dec 20217:16 amRNSFinal Results
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
10th Dec 20212:06 pmRNSSecond Price Monitoring Extn
10th Dec 20212:00 pmRNSPrice Monitoring Extension
5th Nov 20217:00 amRNSDate of Results
26th Oct 20219:05 amRNSSecond Price Monitoring Extn
26th Oct 20219:00 amRNSPrice Monitoring Extension
18th Oct 20217:00 amRNSNotice of Results
20th Sep 202111:49 amRNSResult of Oversubscribed Fundraising
20th Sep 20217:01 amRNSPrimaryBid Offer
20th Sep 20217:00 amRNSProposed Placing and Subscription
1st Sep 20217:00 amRNSUS Small Business Administration Loan Agreement
19th Aug 20217:00 amRNSHigh Performance Garments – Used in Tokyo
16th Aug 20217:51 amRNSFiling of Joint Patent with Airbus
2nd Aug 20217:00 amRNSIssue of Warrants
12th Jul 20217:00 amRNSCollaboration agreement with ProMake Limited
28th May 20212:05 pmRNSSecond Price Monitoring Extn
28th May 20212:01 pmRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSExtension to CeramycGuard Distributor Agreement
6th Apr 20217:00 amRNSFeasibility Study Award
29th Mar 20217:00 amRNS401 Tech Bridge Partners with Haydale
26th Mar 202111:11 amRNS£1.1 million Innovate UK Loan Agreement
25th Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSBiwater Trial CeramycShield™ Treatment
26th Feb 20214:40 pmRNSSecond Price Monitoring Extn
26th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSInterim Results
9th Feb 20217:00 amRNSFunctionalised Masterbatch Used in Bolflex Sole
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSSales Representation Agreement and Trading Update
18th Jan 20219:00 amRNSPrice Monitoring Extension
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 20209:05 amRNSSecond Price Monitoring Extn
15th Dec 20209:00 amRNSPrice Monitoring Extension
8th Dec 202012:09 pmRNSResult of AGM
7th Dec 202012:30 pmRNSDistributor Agreement for iCraft PPE Mask
27th Nov 20207:00 amRNSFunctionalised Graphene Antibacterial Masks
18th Nov 20204:40 pmRNSSecond Price Monitoring Extn
18th Nov 20204:35 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSNotice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.